tag

Hamad Medical Corporation (HMC) has launched two advanced diagnostic services for pediatric allergies: skin allergy testing to accurately identify food and environmental allergens, and food and drug challenge tests, the internationally recognised gold standard for confirming or ruling out allergic conditions under specialist medical supervision.The services are provided through the pediatric clinics at the Ambulatory Care Center and aim to enhance the accuracy of early diagnosis, improve the quality of specialised care provided to children, and reduce allergy-related complications.Dr. Mohammed Al Amri, Deputy Chief Executive Officer and Medical Director at Hamad General Hospital, and Chair of the Pediatrics Departments at HMC, emphasised that the launch of these two services reflects HMC's commitment to providing advanced diagnostic care that enhances children's health and empowers families to make treatment decisions based on accurate and reliable medical evidence.The two services utilise more accurate and specialized diagnostic approaches in pediatric allergy, contributing to early diagnosis, reducing allergy-related complications, and supporting individualized treatment plans for each patient. They also provide families with guidance and education on managing allergic conditions in children, including emergency action plans.The clinic accepts referrals from Primary Health Care Centers, HMC hospitals, and Pediatric Emergency Centers for children aged 6 months to 14 years. It offers early diagnosis and specialized follow-up care through a multidisciplinary team specializing in pediatric allergy.Skin allergy testing provides an accurate assessment of food and environmental allergies in children. It is one of the key tools used in diagnosing allergic conditions, as it helps doctors identify allergy triggers more precisely when combined with clinical evaluation and laboratory tests. Early and accurate diagnosis also helps prevent life-threatening allergic reactions such as anaphylaxis, in addition to supporting families and schools with clear plans for managing emergency situations.The second service is the pediatric food and drug challenge testing clinic. Food challenge tests help reassess certain cases of food allergies in children. After appropriate medical evaluation, some foods can be safely reintroduced into the diets of certain children, even though they were previously avoided.Regarding drug allergies, the clinic provides specialised drug allergy testing, including confirmation of penicillin allergy cases. Global studies have found that when patients diagnosed with "penicillin allergy” undergo a detailed specialist evaluation, a large proportion of them are not actually allergic, which highlights the importance of re-evaluating these cases as an important step to improve antibiotic use and avoid inappropriate treatments.Dr. Aba Mohammed Al Kaabi, Senior Consultant and Section Head of Pediatric Allergy at Hamad General Hospital, emphasised the importance of early assessment of food allergy cases in children and the promotion of healthy nutrition practices, including the gradual and safe reintroduction of certain foods according to appropriate medical recommendations for each case.She noted that early assessment not only protects the child’s health but also reduces the burden on families and provides them with official medical confirmation that contributes to improving their daily quality of life.

Hamad Medical Corporation (HMC), represented by the Nuclear Medicine Molecular Imaging section of the Clinical Imaging Department, has been accredited by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), USA, as a Radiopharmaceutical Therapy Centre of Excellence.This recognition represents a significant milestone for HMC, placing it among the first centers outside the United States to receive this prestigious accreditation. It underscores the organization’s commitment to delivering advanced, high-quality radiopharmaceutical therapy services in line with international standards.This accreditation reflects HMC’s dedication to providing therapy procedures to patients with the highest levels of quality, safety, and excellence. The team’s focus on precision, personalized, and targeted treatments continues to improve outcomes and enhance the patient experience.Chief Radiologist at HMC Dr. Maryam Al Kuwari said: "Being recognized among the first centers outside the United States to achieve this distinction shows the strength of our capabilities and our focus on patient safety and personalized treatment. We are proud of this achievement and remain committed to advancing nuclear medicine services for our patients."Currently, the Nuclear Medicine Molecular Imaging section in HMC provides treatment for six benign and malignant conditions, demonstrating its growing capability and leadership in this specialized field. The department continues to expand its services and innovate to meet the evolving needs of patients in Qatar and beyond.

Hamad Medical Corporation (HMC) and Qatar University (QU) have signed a new agreement establishing a Joint Research Funding Initiative.The agreement aims at strengthening collaboration between the two institutions and supporting research that addresses national health priorities.The new funding initiative is designed to support collaborative research projects that align with the strategic priorities of both organisations and contribute to Qatar’s broader research and healthcare objectives. The initiative will also complement existing internal research funding programs within both institutions.Commenting on the agreement, Chief of Scientific, Academic, and Faculty Affairs HMC, Dr. Jassim Al Suwaidi, said: "This initiative represents an important step in further strengthening cooperation between Hamad Medical Corporation and Qatar University. By supporting collaborative, institution-led research, we are creating new opportunities for clinicians, researchers and academics to work together on projects that address national health priorities and contribute to the advancement of healthcare in Qatar. Through this joint funding initiative, we aim to foster innovation, build research capacity and generate evidence that supports improved patient outcomes and informs future healthcare delivery".On this occasion, Vice President for Research and Innovation at Qatar University, Professor Aiman Erbad, stated: "This agreement reflects the depth of the cooperation between Qatar University and Hamad Medical Corporation and underscores our shared commitment to advancing the research and innovation ecosystem in ways that address national health priorities.The Joint Research Funding Initiative provides an important platform for fostering interdisciplinary collaboration among researchers, clinicians, and academics, while facilitating the translation of scientific knowledge into practical solutions that enhance population health and improve the quality of healthcare services.At Qatar University, we believe that building impactful research partnerships with leading national institutions is fundamental to achieving research excellence and maximizing the societal impact of research, in alignment with Qatar National Vision and the country's aspirations to build a knowledge-based economy".The new agreement will see the establishment of a joint HMC-QU committee to oversee the initiative and ensure that funded projects deliver meaningful impact.The committee will be responsible for identifying and reviewing annual research priority areas, evaluating research proposals, selecting projects for funding, and monitoring the progress and outcomes of funded research. The agreement is expected to support more than three collaborative research projects annually.The agreement further strengthens collaboration in developing Qatar’s healthcare workforce and research environment. HMC and QU have collaborated extensively to provide clinical education and training opportunities for students across medicine, pharmacy, health sciences and related disciplines.Both institutions have also supported joint research projects, co-funded research initiatives, PhD research, faculty exchange programs and collaborative efforts to increase research capacity and scientific output.Noteworthy, HMC and QU have collaborated extensively to provide clinical education and training opportunities for students in medicine, pharmacy, health sciences, and related disciplines.The partnership has also supported collaborative research projects, jointly funded research initiatives, doctoral research, faculty exchange programs, and collaborative efforts aimed at bolstering research capacity and scholarly output.

Hamad Medical Corporation has reaffirmed its commitment to ensuring uninterrupted access to medicines for patients across Qatar, backed by a sustainable strategic stockpile aimed at meeting healthcare needs at all times.Executive Director of Pharmacy at HMC Dr Ameena Jesaimani said the corporation remains keen to guarantee that all patients in the country can obtain their medicines in a secure, smooth and efficient manner. She stressed that HMC pharmacies continue to operate with a strong strategic reserve in place to ensure patient requirements are consistently met.Dr Jesaimani said patient convenience remains a central part of HMC’s approach, noting that medicines continue to be delivered to homes through a service run in co-operation with Qatar Post. Patients can access the service through the Lbaih mobile application or by calling the National Healthcare Helpline 16000, selecting pharmaceutical services, where a professional team prepares prescriptions and ensures their safe delivery to homes.The reassurance comes as Qatar’s healthcare sector continues to strengthen service continuity and patient support through a broad range of measures introduced in recent weeks. Health authorities have maintained normal operations across facilities while also expanding remote access to care, helping patients receive medical guidance, consultations and follow-up services without unnecessary travel.Urgent care services have remained available around the clock at a number of health centres for patients with non-life-threatening conditions, while telephone and video consultations have continued to offer added convenience, particularly for families, the elderly and those managing chronic illnesses.Nurse-led support services have also helped direct patients to the most appropriate level of care, ensuring timely medical attention and easing pressure on emergency departments.Prescription access has been further supported through digital channels, making it easier for patients to request refills, manage appointments and obtain key health services remotely. These steps reflect a wider emphasis on combining direct care with technology-driven solutions to improve access, efficiency and patient comfort.At the same time, Qatar has continued to reinforce the resilience of its wider healthcare supply system. Efforts to protect the steady flow of medicines and medical supplies have been supported by strong logistics planning, co-ordination across institutions and the availability of alternative transport arrangements when needed. This has helped ensure that essential healthcare goods continue to reach hospitals, clinics and patients without disruption.The country has also pressed ahead with longer-term health priorities, including preventive care, regulatory improvements and community health initiatives. Public institutions and partner entities have continued to invest in programmes that support quality treatment, early intervention and safer, more accessible services for the population. 

A total of 641 older adults have been treated at the specialist Sarcopenia Clinic of Hamad Medical Corporation (HMC) since its opening in 2023, with new patient registrations increasing by 83% in 2025 compared to 2024, highlighting the growing need for specialist care that supports healthy ageing. The Sarcopenia Clinic provides comprehensive care for patients with sarcopenia, a condition that causes age-related loss of muscle strength and physical function. The World Health Organisation (WHO) recognises sarcopenia as a major health issue linked to falls, disability, hospital admission and loss of independence among older adults. The clinic supports healthy ageing through early identification, thorough assessment and evidence-based treatment approaches. It aligns with national health priorities and WHO Healthy Ageing principles, with a strong focus on prevention and maintaining daily function. Care is delivered through a multidisciplinary team that includes geriatric doctors, physiotherapists, dietitians and nursing staff. Together, the team provides personalised care plans based on each patient’s needs, goals and physical ability. Patients through the treatment are benefitted from early detection of sarcopenia and pre-sarcopenia; comprehensive geriatric assessment and frailty-focused care; bioelectrical impedance analysis (BIA) to measure muscle mass; personalised strength and functional exercise programmes; targeted nutrition advice and regular reassessment and follow-upClinical results show clear improvements in muscle strength, balance, walking speed and overall mobility after treatment. Beyond physical improvements, many patients report feeling more confident, more active and better able to manage daily activities. Patients who were previously at high risk of falls have shown safer movement and improved independence. Patient and caregiver feedback has been very positive, highlighting the clinic’s supportive approach, clear guidance and practical education on muscle health. 

In a breakthrough that moves treatment from repeated stop-gap procedures to a permanent cure, Hamad Medical Corporation has carried out Qatar’s first robotic bilateral ureteric reimplantation, giving a patient a definitive solution to a complex urinary obstruction and signalling a major advance in local urological care.The pioneering surgery was performed at Aisha Bint Hamad Al Attiyah Hospital and involved reattaching both ureters — the tubes that carry urine from the kidneys to the bladder — using robotic technology. While the procedure itself is well-established internationally, it had previously been done in Qatar only through open surgery. This marks the first time it has been completed robotically in the country.Traditionally, patients with this condition could only be managed using temporary measures, such as repeated stent replacements. These procedures carry ongoing risks, including infection, bleeding, pain, and lower urinary tract symptoms, as well as the cumulative risks associated with multiple anesthetics. The introduction of robotic surgery allows surgeons to perform this complex procedure with greater precision, reduced risk, and significantly faster recovery for patients.For the patient, the outcome has been life-changing. Patient is now completely stent-free, with normal urine flow from the kidneys to the bladder, and has made a full recovery, no longer requiring repeated hospital visits, imaging, or procedures. Most importantly, the obstruction has been repaired, ensuring his kidneys are protected and functioning normally.The introduction of robotic bilateral ureteric reimplantation at HMC represents a major step forward in patient care. It reduces the need for repeated surgical interventions, lowers the risk of recurrent infections, and minimizes long-term follow-up requirements for both patients and healthcare services.This milestone reflects HMC's commitment to moving beyond temporary treatment options and delivering definitive, high-quality surgical care through the adoption of advanced medical technologies. By expanding the use of robotic surgery, HMC continues to improve clinical outcomes, enhance recovery, and significantly improve quality of life for patients.This achievement further strengthens HMC's role as a national and regional leader in complex urological and robotic surgery, ensuring patients in Qatar have access to world-class care close to home. 

The Ministry of Public Health (MoPH) concluded a four-day workshop on Health System Performance Assessment (HSPA) Indicators at the Itqan Simulation and Training Centre.The event brought together more than 300 participants from the public, private and semi-public health sectors. Sixteen speakers from the MoPH, Hamad Medical Corporation and Primary Health Care Corporation contributed to the programme.The workshop focused on strengthening a shared, data-driven approach to understanding how Qatar’s health system performs, a statement said. Sessions covered key areas such as patient safety, access to care, clinical effectiveness and system capacity.Participants explored how indicators are defined, measured and interpreted, and discussed how these insights can be used to improve services for patients and communities.The event provided an opportunity for participants to engage directly with indicator owners, clarify reporting methods and promote consistency across facilities. The MoPH highlighted that standardised and benchmarked performance measurement remains essential to achieving excellence in healthcare.The workshop marked an important step in supporting this commitment, the statement added. 

The National Centre for Cancer Care and Research (NCCCR), part of Hamad Medical Corporation, has announced the granting of official accreditation by the Arab Board of Health Specialisations (ABHS) to Qatar, with the NCCCR as a recognised training centre for the Medical Oncology Fellowship Programme.This accreditation reflects the NCCCR’s dedication to excellence in cancer education, clinical training, and professional advancement.Through this recognition, NCCCR further strengthens its position as a regional leader in oncology training, enabling physicians from Qatar and across the Arab world to pursue specialised medical oncology education that meets international standards. 

Qatar University (QU) celebrated the graduation of the 14th cohort of the Empower Generations Consortium, a national initiative dedicated to investing in Qatari talent in the fields of life sciences, health sciences, and scientific research.Established in support of Qatar National Vision 2030, the Consortium is a collaborative ecosystem led by QU, bringing together more than 13 partners from the health and education sectors, including the Ministry of Education and Higher Education (MoEHE), the official sponsor; Qatar Precision Health Institute; Qatar Foundation; Hamad Medical Corporation (HMC); the Ministry of Public Health; the Primary Health Care Corporation (PHCC); Sidra Medicine; Gannas Qatari Society; the Qatar Falcon Genome Project; and the Veterinary Medicine Center, along with two international partners: Fractal Up Center for Artificial Intelligence Research and the Africa Research Project (ARP).**media[386933]**The ceremony was attended by Prof Asma al-Thani, vice president for Medical Sciences and director of the Biomedical Research Center at QU, along with several university vice presidents, deans of health and medical sciences colleges, and representatives from the MoEHE. In her remarks, Fatima al-Obaidli, assistant director at the MoEHE, praised QU’s efforts and the Empowering Generations Consortium programmes for their role in enhancing students’ skills and preparing them for the future.**media[386934]**The 14th cycle of the Consortium began in November 2025 and continued for two weeks of separate training programmes for male and female students. A total of 23 high schools and 150 Qatari students participated in three projects: Health, the Genomics and Precision Medicine Project, and Qatar Scientists of Biodiversity. The programme concluded with separate recognition ceremonies for the female and male participants.**media[386935]**During the ceremony, Dr Abdulla al-Yafei, president's executive assistant for administrative operations at QU, delivered a speech highlighting the success of the 14th cycle. He noted that the programme received 620 applications, of which 150 were selected to join the specialised training across various fields. He recalled that the Consortium was established in 2013 to support Qatar National Vision 2030 and comprises 13 partners across the health, research, and education sectors.He added that the Consortium has significantly contributed to raising the number of Qatari students in the health and medical programmes at QU from 6% in 2013 to 43% in 2025. He also noted the Consortium ’s achievements, including published research in peer-reviewed journals, documented effectiveness through comprehensive databases, and multiple international awards. Dr al-Yafie reiterated QU’s commitment to empowering students through comprehensive hands-on training environments and expressed gratitude to all partners for their continued support.The event concluded with the presentation of honorary certificates to participating schools across Qatar and to the students, awarded by the MoEHE. 

University of Doha for Science and Technology (UDST) hosted the 4th symposium on Diabetes Care under the theme “Transforming Diabetes Care for Well-Being: Innovations in Education, Research, and Person-Centred Practice.”Held in collaboration with Hamad Medical Corporation (HMC), and with the support of the Ministry of Public Health (MoPH), Primary Health Care Corporation, Sidra Medicine, and The View Hospital in affiliation with Cedars-Sinai, the symposium brought together national and international healthcare experts to discuss the latest advances, challenges and opportunities in diabetes care and prevention as well as the broader metabolic health agenda.The symposium was attended by Sheikh Dr Mohammed al-Thani, director of Non-Communicable Diseases Prevention Programmes at the MoPH; Dr. Rachid Benlamri, vice president, academics UDST; Dr Rayana Ahmed Bou Haka, director of the World Health Organisation Office, Qatar; Dr Dabia al-Mohanadi, director of the Qatar Metabolic Institute and division chief of Endocrinology at HMC; Dr Abdulla al-Hamaq, executive director of Qatar Diabetes Association; Prof Amanda Adler, professor of Diabetic Medicine and Health Policy at the University of Oxford, UK; and Dr Tassos Kotzias, president of the Doha Chapter of the International Coaching Federation, and several researchers, faculty, students and guests.The event featured an extensive scientific programme including keynote lectures, expert talks, and interactive panel discussions covering topics such as diabetes remission, innovations in cardiovascular and Atherosclerotic Cardiovascular Disease risk management, holistic and person-centred care, and the integration of mental health and behaviour change in diabetes management.Dr Salem al-Naemi, president of UDST, stated: “At UDST, we take pride in fostering platforms that connect education, research, and healthcare practice to address some of Qatar’s most pressing health priorities. The 4th Symposium on Diabetes Care reflects our shared mission to build capacity among healthcare professionals, support innovation in diabetes education, and contribute to the nation’s collective efforts to reduce the burden of chronic diseases.”Dr Dabia said: “Our shared goal is to deliver care that is innovative, compassionate and truly integrated - centred on the person, not just the condition. As we address diabetes alongside obesity and cardiovascular disease, we recognise that these conditions are deeply interconnected and require coordinated, multidisciplinary solutions.”The symposium also featured a high-level panel discussion on the National Health Strategy (NHS-3), 2024 - 2030, Action Plan on Obesity, Diabetes and Modifiable Risk Factors for Atherosclerotic Cardiovascular Disease emphasising ongoing efforts to advance childhood obesity prevention and strengthen integrated, multidisciplinary approaches to non-communicable diseases care across Qatar.An accompanying exhibition highlighted the contributions of key healthcare institutions and academic organisations actively engaged in diabetes care, research, and education in Qatar.

Hamad Medical Corporation (HMC) is expanding and enhancing its services to improve bone health and reduce the impact of osteoporosis through specialist clinics, early diagnosis and comprehensive treatment options across its facilities.Affecting around 30% of women and 10% of men over the age of 50, osteoporosis leads to a reduction in bone density and strength, increasing the risk of fractures, mainly in the hips, spine, and wrists. Osteoporosis is often referred to as a silent disease, with many people unaware of the condition until experiencing a fracture. HMC continues to focus its efforts on raising awareness, promoting early diagnosis and prevention, and providing timely and effective care for those at risk.HMC offers a full range of specialist services that support patients through every stage of osteoporosis management. Dedicated osteoporosis clinics operate across several HMC facilities, providing individualised assessment and care for patients at risk of or living with osteoporosis. Advanced diagnostic tools, including dual-energy X-ray absorptiometry scanning with Vertebral Fracture Assessment and Trabecular Bone Score are available to enable accurate and early diagnosis.In addition, a specialist Fracture Liaison Clinic at the Bone and Joint Center ensures co-ordinated care for patients recovering from fractures and works to prevent future injuries. A full selection of approved osteoporosis medications - oral, subcutaneous, and intravenous - are available and prescribed based on each patient’s clinical needs. HMC encourages members of the public, especially those with risk factors such as age, menopause, or family history of fractures, to speak with their family physician about screening for osteoporosis, while regularly exercising and eating a diet rich in calcium and vitamin D to help strengthen bones. The FRAX online tool is used by healthcare teams and patients to predict the 10-year risk of fractures caused by osteoporosis.This electronic system calculates and tracks key factors that should be considered when managing osteoporosis, enabling treatment decisions to be based on fracture risk assessment rather than bone density measurements alone.

The Hamad Medical Corporation (HMC) has organised the 2025 Person-Centred Care (PCC) Middle East Forum. The event was attended by HE the Minister of Public Health Mansoor bin Ebrahim bin Saad al-Mahmoud and HE the HMC managing director Mohammed bin Khalifa al-Suwaidi, along with regional and international healthcare leaders, professionals, and innovators committed to advancing person-centred approaches to healthcare transformation. Delivered by the HMC in partnership with US-based Planetree International, the forum has established itself as the region’s premier platform for sharing best practices and innovations that place patients and families at the heart of care. This year’s theme, *Shaping the Future of Care: Innovations in Person-Centered Care, focused on how innovation, integration and inclusivity are reshaping healthcare delivery across systems and communities. The programme featured three key tracks: Person-Centred Digital Transformation, Collaborative Care; Building Partnerships for Better Outcomes, and Care Beyond Boundaries; and Systematic Personalisation Across Networks. Throughout the two-day event, speakers and delegates explored how emerging technologies, collaborative partnerships and co-designed models of care can enhance patient experience and clinical outcomes. The forum highlighted the HMC’s leadership in embedding person-centred care across its network – from pioneering digital tools such as the Lbaih mobile app, which enables patients to access and manage their healthcare information via their mobile devices, to establishing Qatar’s first AI Centre of Excellence driving the development of SMART hospital frameworks. Beyond technology, the HMC’s person-centred approach has established the Person-Centred Care Ambassadors Programme, empowering volunteers from diverse backgrounds, cultures and professions to enrich the hospital experience of patients and families through compassionate service and meaningful interaction. Another example is the HMC’s Patient and Family Advisory Council (PFAC), a collaborative group of patients, family members and caregivers who partner with HMC teams to shape programmes, services, and initiatives. Through the PFAC, the perspectives and lived experiences of patients directly influence care delivery, ensuring that services truly reflect their needs and expectations.